Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Palestinians shut West Bank schools to contain coronavirus variants

Published 02/27/2021, 11:16 AM
Updated 02/27/2021, 01:15 PM
© Reuters. A Palestinian man walks past a closed school, amid the coronavirus disease (COVID-19) outbreak, in Ramallah in the Israeli-occupied West Bank

© Reuters. A Palestinian man walks past a closed school, amid the coronavirus disease (COVID-19) outbreak, in Ramallah in the Israeli-occupied West Bank

By Zainah El-Haroun

RAMALLAH, West Bank (Reuters) - Schools in the occupied West Bank will shut down for 12 days in an effort to stop a sharp rise in coronavirus variant infections, Palestinian Prime Minister Mohammed Shtayyeh said on Saturday.

High schools will be exempt from the closure which will begin on Sunday, Shtayyeh said in a televised address, adding the new restrictions were prompted by a large number of cases of the British and South African variants in the territory.

Intensive care units for COVID-19 patients have reached 95% occupancy in the West Bank and schools have been identified as a major cause for the fast spread of infections, the Ministry of Health said.

On Thursday, it reported that a randomised sample of coronavirus patients showed that more than three-quarters were infected with the British variant.

The World Bank said in a report this week that the Palestinian territories have one of the lowest testing rates in the Middle East and North Africa and that the positivity rate in the West Bank is over 21%, and in Gaza 29%, indicating an uncontrolled spread of the pandemic.

The West Bank, where 3.1 million Palestinians live, has reported a total of 118,519 coronavirus cases and 1,406 deaths.

Gaza, where coronavirus restrictions have gradually been lifted since January, has reported 55,091 cases and 549 deaths within its population of 2 million.

With around 32,000 vaccine doses in hand to date, the Palestinians launched limited vaccination programmes in the West Bank and Gaza this month, beginning with health workers.

The Palestinian Authority (PA) expects to receive an initial COVAX shipment within weeks and says it also has supply deals with Russia and drugmaker AstraZeneca (NASDAQ:AZN), although doses have been slow to come. Shtayyeh said he expected shipments in March.

© Reuters. A Palestinian man walks past a closed school, amid the coronavirus disease (COVID-19) outbreak, in Ramallah in the Israeli-occupied West Bank

Israel has donated 2,000 doses to the PA but has come under criticism for not supplying more vaccines to the Palestinians. It argues that under interim peace accords the PA is responsible for vaccinations in Gaza and the West Bank.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.